Exelixis | Betriebsergebnis



Operating Profit Veränderung Datum
Acadia Pharmaceuticals USD 32.37M 13.08M 2025-06
Agios Pharmaceuticals USD -127056000 20.43M 2025-06
Amgen USD 2.66B 1.37B 2025-06
AstraZeneca USD 3.51B 166M 2025-06
Bayer EUR 13M 2.31B 2025-06
BioMarin Pharmaceutical USD 276.89M 52.99M 2025-06
Bristol-Myers Squibb USD 3.77B 366M 2025-06
Cytokinetics USD -111506000 44.12M 2025-06
Eisai JPY 20.74B 21.77B 2025-06
Eli Lilly USD 7.02B 1.61B 2025-06
Exelixis USD 215.68M 28.82M 2025-07
Genmab DKK 360M 172M 2025-06
Glaxosmithkline GBP 702M 513M 2024-12
Incyte USD 310.82M 105.66M 2025-06
Ionis Pharmaceuticals USD 139.84M 285.84M 2025-06
MacroGenics USD -16587000 70.78M 2024-12
Merck USD 6.36B 494M 2025-06
Moderna USD -907000000 143M 2025-06
Neurocrine Biosciences USD 145.6M 121.9M 2025-06
Novartis USD 4.86B 201M 2025-06
Pfizer USD 2.6B 1.06B 2025-06
Sanofi EUR 861M 2.77B 2024-12
Takeda JPY 184.56B 259.5B 2025-06
Ultragenyx Pharmaceutical USD -193567000 50.63M 2025-06
Xencor USD -33172000 10.01M 2025-06


Exelixis Betriebsergebnis - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.